>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
非编码RNA HOTAIR和MALAT1在非小细胞肺癌患者血清及支气管肺泡灌洗液中表达水平的临床意义
作者:黄佳茹  赵云峰  丁薇 
单位:上海市浦东新区浦南医院 呼吸科, 上海 200125
关键词:非编码RNA Hox转录反义RNA 肺腺癌转移相关转录本1 非小细胞肺癌 
分类号:R734.2
出版年·卷·期(页码):2019·38·第四期(682-686)
摘要:

目的:探讨非编码RNA HOTAIR和MALAT1在非小细胞肺癌(NSCLC)患者血清及支气管肺泡灌洗液(BALF)中表达水平的临床意义。方法:提取NSCLC组86例患者及对照组30例患者血清和BALF中总RNA,用实时荧光定量RT-PCR检测HOTAIR和MALAT1基因的表达水平并分析其与NSCLC患者临床病理因素的关系,同时分析BALF中HOTAIR和MALAT1的诊断效能。结果:NSCLC组患者血清中HOTAIR表达水平显著高于对照组,但MALAT1的表达水平却低于对照组,差异均有统计学意义(P<0.05)。NSCLC组患者BALF中HOTAIR、MALAT1相对表达水平明显高于对照组,且肿瘤越大,恶性程度越高,其表达水平越高;此外,腺癌患者BALF中MALAT1表达量(1.03±0.26)较鳞癌患者(0.64±0.08)明显增高(P<0.05)。根据约登指数最大法选取BALF中HOTAIR、MALAT1表达量分别为5.16、0.92作为最佳截断值时,诊断肺癌的敏感度分别为73.5%、82.3%,特异度分别为85.4%、87.6%。结论:HOTAIR、MALAT1在NSCLC患者支气管肺泡灌洗液中呈高水平表达,敏感度和特异度较高,对于NSCLC的辅助诊断具有一定的指导价值。

Objective: To investigate the clinical significance of non-coding RNA HOTAIR and MALAT1 expression levels in serum and bronchoalveolar lavage fluid (BALF) of patients with non-small cell lung cancer (NSCLC). Methods: Total RNA in serum and BALF was extracted from 86 NSCLC patients and 30 healthy people, and the expression levels of HOTAIR and MALAT1 genes were detected by real-time fluorescence quantitative RT-PCR, and their correlation with clinicopathological factors in NSCLC patients was analyzed. Meanwhile, the diagnostic efficacy of HOTAIR and MALAT1 in BALF was analyzed. Results: The expression level of HOTAIR in the serum of NSCLC patients was significantly higher than that of the healthy control group, but the expression level of MALAT1 was lower than that of the healthy control group, with statistically significant differences (P<0.05).The relative expression levels of HOTAIR and MALAT1 in BALF of NSCLC patients were significantly higher than those in the healthy control group. In addition, the relative expression level of MALAT1 in BALF of adenocarcinoma patients (1.03±0.26) was significantly higher than that of squamous cell carcinoma patients (0.64±0.08) (P<0.05).The sensitivity and specificity of HOTAIR in bronchoalveolar lavage fluid of NSCLC patients were 73.5% and 82.3%, respectively (cut off value was 5.16), while the sensitivity and specificity of MALAT1 were 85.4% and 87.6%, respectively (cut off value was 0.92). Conclusion: HOTAIR and MALAT1 are highly expressed in bronchoalveolar lavage fluid of NSCLC patients with high sensitivity and specificity, which has certain guiding value for the auxiliary diagnosis of NSCLC.

参考文献:

[1] REBECCA L S,KIMBERLY D M,AHMEDIN J.Cancer statistics[J].CA Cancer J Clin,2019,69:7-34.
[2] WU Y,HUANG C,MENG X,et al.Long noncoding RNA MALAT1:insights into its biogenesis and implications in human disease[J].Curr Pharm Des,2015,21(34):5017-5028.
[3] JIANG C,LI X,ZHAO H,et al.Long non-coding RNAs:potential new biomarkers for predicting tumor invasion and metastasis[J].Mol Cancer,2016,15(1):62.
[4] HAJJARI M,SALAVATY A.HOTAIR:an oncogenic long non-coding RNA in different cancers[J].Cancer Biol Med,2015,12(1):1-9.
[5] SCHMIDT L H,SPIEKER T,KOSCHMIEDER S,et al.The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth[J].J Thorac Oncol,2011,6(12):1984-1992.
[6] JAKUBOWSKA K,NAUMNIK W,NIKLIN W,et al.Clinical significance of HMGB-1 and TGF-b level in serum and BALF of advanced non-small cell lung cancer[J].Adv Exp Med Biol,2015,852:49-58.
[7] RICCIUTI B,MECCA C,CRINO L,et al.Non-coding RNAs in lung cancer[J].Oncoscience,2014,1(11):674-705.
[8] QI P,ZHOU X Y,DU X.Circulating long non-coding RNAs in cancer:current status and future perspectives[J].Mol Cancer,2016,15(1):39.
[9] LOEWEN G,JAYAWICKRAMARAJAH J,ZHUO Y,et al.Functions of lncRNA HOTAIR in lung cancer[J].J Hematol Oncol,2014,7:90.
[10] LIU X H,LIU Z L,SUN M,et al.The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer[J].BMC Cancer,2013,13:464.
[11] 林梦洁,陈志强,尹凌帝,等.长链非编码RNA HOTAIR对非小细胞肺癌迁移和侵袭能力的影响[J].临床肿瘤学杂志,2014,19(8):684-689.
[12] SHEN L,CHEN L,WANG Y,et al.Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transiton in lung cancer[J].J Neurooncol,2015,121(1):101-108.
[13] FENGJIE G,FANG Y,JING W,et al.Expression of MALAT1 in the peripheral whole blood of patients with lung cancer[J].Biomed Rep,2015,3(3):309-312.
[14] 石婷,高戈,曹颖丽.非小细胞肺癌患者血清中MALAT1表达水平及其临床意义[J].临床检验杂志,2016,34(2):114-117.
[15] GUTSCHNER T,HAMMERLE M,EISSMANN M,et al.The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells[J].Cancer Res,2013,73(3):1180-1189.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405943 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364